USPTO serial 99811070
Reviewed by CopyMark Law Group
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Knoxville, TN, US
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Stacy J. Grossman
Stacy J. Grossman SGIP500 Mamaroneck Ave, Suite 320Harrison, NY 10528United States| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for skin care; Pharmaceutical preparations for treating asthma; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Fertility enhancement preparations; Nutritional supplements; Dietary supplements; Weight management supplements; Pharmaceutical preparations for weight management, weight loss, and the maintenance of weight loss; Medicinal preparations for weight management, weight loss and the maintenance of weight loss; Medicated hair care preparations; Vitamins; Medicated skin care preparations; Pharmaceutical preparations for the treatment of menopausal and perimenopausal symptoms; Medicated skin preparation for use in treating menopausal and perimenopausal symptoms; Medicated dermatological preparations and substances | ACTIVE | — |
| 009 | Downloadable software in the nature of a mobile application for accessing personalized telemedicine visits and obtaining prescription medications | ACTIVE | — |
| 041 | On-line journals, namely, blogs featuring information in the fields of healthcare, health and wellness | ACTIVE | — |
| 042 | Platform as a service (PAAS) featuring computer software platforms for accessing personalized telemedicine visits and obtaining prescription medications | ACTIVE | — |
| 044 | Telemedicine services; Nutrition counseling; Blood testing being medical analysis services for diagnostic and treatment purposes provided by medical laboratories | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 27, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 27, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 27, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 24, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| May 8, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 8, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 8, 2026 | NWAP | NEW APPLICATION ENTERED | — |